These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3354661)

  • 1. VIP and its homologues increase vascular conductance in certain endocrine and exocrine glands.
    Huffman LJ; Connors JM; Hedge GA
    Am J Physiol; 1988 Apr; 254(4 Pt 1):E435-42. PubMed ID: 3354661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of thyrotropin on the vascular conductance of the thyroid gland.
    Connors JM; Huffman LJ; Hedge GA
    Endocrinology; 1988 Mar; 122(3):921-9. PubMed ID: 3342758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of vasoactive intestinal peptide on thyroid blood flow and circulating thyroid hormone levels in the rat.
    Huffman L; Hedge GA
    Endocrinology; 1986 Feb; 118(2):550-7. PubMed ID: 3943485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helodermin, but not cholecystokinin, somatostatin, or thyrotropin releasing hormone, acutely increases thyroid blood flow in the rat.
    Huffman L; Michalkiewicz M; Pietrzyk Z; Hedge GA
    Regul Pept; 1990 Nov; 31(2):101-14. PubMed ID: 1980023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscarinic modulation of the vasodilatory effects of vasoactive intestinal peptide at the rat thyroid gland.
    Huffman LJ; Michalkiewicz M; Connors JM; Pietrzyk Z; Hedge GA
    Neuroendocrinology; 1991 Jan; 53(1):69-74. PubMed ID: 2046862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasoactive intestinal peptide treatment that increases thyroid blood flow fails to alter plasma T3 or T4 levels in the rat.
    Huffman LJ; Connors JM; White BH; Hedge GA
    Neuroendocrinology; 1988 Jun; 47(6):567-74. PubMed ID: 3399036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the effects of vasoactive intestinal peptide (VIP) on blood flow through and salivation of the dog salivary gland in comparison with those of secretin, glucagon and acetylcholine.
    Shimizu T; Taira N
    Br J Pharmacol; 1979 Apr; 65(4):683-7. PubMed ID: 435691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of peptides related to VIP and secretin with guinea pig pancreatic acini.
    Zhou ZC; Gardner JD; Jensen RT
    Am J Physiol; 1989 Feb; 256(2 Pt 1):G283-90. PubMed ID: 2465694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of synthetic chicken vasoactive intestinal peptide on pancreatic blood flow and on exocrine and endocrine secretions of the pancreas in dogs.
    Inoue K; Kawano T; Shima K; Kim T; Suzuki T; Tobe T; Takeyama M; Yajima H
    Dig Dis Sci; 1983 Aug; 28(8):724-32. PubMed ID: 6347571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent stimulation of the avian exocrine pancreas by porcine and chicken vasoactive intestinal peptide.
    Dimaline R; Dockray GJ
    J Physiol; 1979 Sep; 294():153-63. PubMed ID: 512939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the vasodilatory effects of vasoactive intestinal polypeptide (VIP) and peptide-HI (PHI) in the rabbit and the cat.
    Nilsson SF; Mäepea O
    Acta Physiol Scand; 1987 Jan; 129(1):17-26. PubMed ID: 3565040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid vascular conductance: differential effects of elevated plasma thyrotropin (TSH) induced by treatment with thioamides or TSH-releasing hormone.
    Connors JM; Huffman LJ; Michalkiewicz M; Chang BS; Dey RD; Hedge GA
    Endocrinology; 1991 Jul; 129(1):117-25. PubMed ID: 1905224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of effect of vasoactive intestinal peptide antagonists on blood flow in the rat thyroid.
    Michalkiewicz M; Huffman LJ; Hedge GA
    Peptides; 1991; 12(6):1181-6. PubMed ID: 1815206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of vasoactive intestinal peptide on vascular conductance are unaffected by anesthesia.
    Bouder TG; Huffman LJ; Hedge GA
    Am J Physiol; 1988 Dec; 255(6 Pt 2):R968-73. PubMed ID: 3202229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropeptide control of thyroid blood flow and hormone secretion in the rat.
    Huffman L; Hedge GA
    Life Sci; 1986 Dec; 39(22):2143-50. PubMed ID: 2431247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of renin secretion by vasoactive intestinal peptide.
    Porter JP; Reid IA; Said SI; Ganong WF
    Am J Physiol; 1982 Sep; 243(3):F306-10. PubMed ID: 7051858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of vasoactive intestinal peptide and its homologues on the substance P-mediated secretion of fluid and protein from the rat submandibular gland.
    Iwabuchi Y; Masuhara T
    Gen Pharmacol; 1994 Jul; 25(4):705-11. PubMed ID: 7525400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of repeated infusions of substance P and vasoactive intestinal peptide on the weights of salivary glands subjected to atrophying influences in rats.
    Månsson B; Nilsson BO; Ekström J
    Br J Pharmacol; 1990 Dec; 101(4):853-8. PubMed ID: 1707705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secretin receptor activity in rat gastric glands. Binding studies, cAMP generation and pharmacology.
    Gespach C; Bataille D; Vauclin N; Moroder L; Wünsch E; Rosselin G
    Peptides; 1986; 7 Suppl 1():155-63. PubMed ID: 3018694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation by vasoactive intestinal peptide, histamine, somatostatin-14 and -28 of cyclic adenosine monophosphate levels in gastric glands isolated from the guinea pig fundus or antrum.
    Gespach C; Hui Bon Hoa D; Rosselin G
    Endocrinology; 1983 May; 112(5):1597-606. PubMed ID: 6131813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.